Lockheed Martin is a defensive stock that is somewhat less volatile than other stocks investors might consider.
1 extracted signal · 0 resolved · 1 still active
Parkev Tatevosian, CFA23 Aug 2025, 21:45 UTC
AI-generated source summary
The video presents a fundamental analysis of Lockheed Martin (LMT) stock. It begins by referencing a previous upward trend in the stock market during 2025, with a recent pullback. The presenter discusses Lockwood Martin's most recent quarter reports 18 billion in sales, 800 million in infrastructure and innovation, and 1.3 billion to shareholders. Furthermore there are charges of 1.8 billion over several legacy programs due to high cost of goods.The management focuses on customers national defense with a strong backlog of orders.A proprietary DCF model is used to give an intrinsic value per share of $736.66, based on historical numbers and adjusted historical volatility. The speaker updates the recommendation of the stock as a buy with a forward price to earnings ratio of just 16.3.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Signals in this source
More Prediction Case Files from Parkev Tatevosian, CFA
Coca-Cola Stock: Buy, Hold, or Sell? | KO Stock Analysis
SoFi Stock Analysis: Buy the Dip?
Should You Buy Micron Stock Instead of Nvidia Stock? | MU Stock vs. NVDA Stock
Should You Buy the Dip in Meta Stock? | META Stock Analysis and Live Earnings Review
Should Passive Income Investors Buy Colgate Palmolive Stock?
Procter & Gamble Stock: Buy, Hold, or Sell? | PG Stock Analysis
Parkev Tatevosian, CFA
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.